In vitro interactions of micafungin with amphotericin B against clinical isolates of Candida spp.

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1529-1532

  Serena, Carolina ^a   Mariné, Marçal ^a   Quindós, Guillermo ^b   Carrillo, Alfonso J ^c   Cano, J F ^a   Javier Pastor, F ^a   Guarro, Josep ^a,d  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c Asesoria Cientifica y de Investigacion Aplicada   (Spain)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; MICAFUNGIN;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FUNGUS GROWTH; FUNGUS ISOLATION; GROWTH INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REDUCTION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ECHINOCANDINS; HUMANS; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS;

EID: 42049119155     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01097-07     Document Type: Article

References (21)

1. Andes, D., and N. Safdar. 2005. Efficacy of micafungin for the treatment of candidemia. Eur. J. Clin. Microbiol. 24:662-664.
2. Barchiesi, F., E. Spreghini, S. Tomassetti, D. Giannini, and G. Scalise. 2007. Caspofungin in combination with amphotericin B against Candida parapsilosis. Antimicrob. Agents Chemother. 51:941-945.
3. Clemens, K. V., M. Espiritu, R. Parmar, and D. A. Stevens. 2005. Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrob. Agents Chemother. 49:4867-4875.
4. Eliopoulos, G. M., and R. C. Moellering. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, MD.
5. Reference deleted.
6. Laverdiere, M., D. Hoban, C. Restieri, and F. Habel. 2002. In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. J. Antimicrob. Chemother. 50:119-123.
7. Reference deleted.
8. Mariné, M., C. Serena, F. J. Pastor, and J. Guarro. 2006. Combined anti-fungal therapy in a murine infection by Candida glabrata. J. Antimicrob. Chemother. 58:1295-1298.
9. Reference deleted.
10. Mukherjee, P. K., D. J. Sheehan, C. A. Hitchcock, and M. A. Ghannoum. 2005. Combination treatment of invasive fungal infections. Clin. Microbiol. Rev. 18:163-194.
11. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Olson, J. A., J. P. Adler-Moore, P. J. Smith, and R. T. Proffitt. 2005. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Antimicrob. Agents Chemother. 49:4895-4902.
13. Patterson, T. F. 2005. Advances and challenges in management of invasive mycoses. Lancet 366:1013-1025.
14. Pfaller, M. A., L. Boyken, R. J. Hollis, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2006. Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods. J. Clin. Microbiol. 44:3533-3538.
15. Serena, C., B. Fernandez-Torres, F. J. Pastor, L. Trilles, M. S. Lazera, N. Nolard, and J. Guarro. 2005. In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrob. Agents Chemother. 49:2994-2996.
16. Serena, C., M. Marine, F. J. Pastor, N. Nolard, and J. Guarro. 2005. In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula. J. Antimicrob. Chemother. 55:1020-1023.
17. Serena, C., F. J. Pastor, F. Gilgado, E. Mayayo, and J. Guarro. 2005. Efficacy of micafungin in combination in a murine model of disseminated trichosporonosis Antimicrob. Agents Chemother. 49:497-502.
18. Spellberg, B. J., S. G. Filler, and J. E. Edwards. 2006. Current treatment strategies for disseminated candidiasis. Clin. Infect. Dis. 42:244-251.
19. Swinne, D., M. Watelle, and N. Nolard. 2005. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates. Rev. Iberoam. Micol. 22:24-28.
20. Tavanti, A., A. D. Davidson, N. A. R. Gow, M. C. J. Maiden, and F. C. Odds. 2005. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J. Clin. Microbiol. 43:284-292.
21. Yustes, C., and J. Guarro. 2005. In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp. Antimicrob. Agents Chemother. 49:3498-3500.